About Us
What We Do
Backed by ASCO, CancerLinQ’s products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. We are bilingual by design: fluent in both the language of oncology and technology. As a trusted partner to over 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance cancer care and research.
Why We Do It
CancerLinQ envisions a new paradigm where all people with cancer have equitable access to quality care and clinical research options. CancerLinQ aims to narrow the gap between cancer care delivery and clinical research, empowering oncology care teams and researchers to learn from every patient at the point of routine care.
CancerLinQ Community
CancerLinQ has built a community of learning across different platforms, disciplines, and skillsets, to enable improvements in care that can reach patients everywhere. CancerLinQ collaborates with medical and patient organizations, government agencies, health care companies, and others to share and constantly improve data, technology, and insights. To benefit every patient, we need every oncology professional to join the CancerLinQ community of learning. Contact us at info@cancerlinq.org to learn more.
Leadership
CancerLinQ Advisory Committees
CancerLinQ Committees have representation from patients, physicians, researchers, and other industry collaborators to advise CancerLinQ leadership and staff, and provide expertise, experience, and perspectives to better enable the learning health system.
Participating Cancer Centers and Community Oncology Practices
Since its launch in 2014, the CancerLinQ network has rapidly grown from a foundational group of Vanguard Practices to a national coalition of organizations across the cancer care continuum, including large institutions, community practices, safety net hospitals, and academic medical centers. These participating organizations provide CancerLinQ with diverse data that represent the spectrum of practice settings, encompass all cancer types, and real-world variability in patient age, race, and ethnicity.
Industry Collaborators
